Back to Search
FARID BOULAD, MD
MD
Pediatric Hematology & Oncology Physician
NPI: 1619948353Individual
Specialties, Licenses & Credentials
Pediatric Hematology & Oncology PhysicianPrimary
Pediatrics — Pediatric Hematology-Oncology
Code: 2080P0207X
184016(NY)
Research & Publications (20)
Stem cell transplantation for the treatment of Fanconi anaemia using a fludarabine-based cytoreductive regimen and T-cell-depleted related HLA-mismatched peripheral blood stem cell grafts.
PMID 11167755·Br J Haematol·2000
5-case
Splenic infarction and subsequent splenic rupture in a patient with paroxysmal nocturnal hemoglobinuria and heparin-induced thrombocytopenia.
PMID 19415735·Pediatr Blood Cancer·2009
5-case
Disorders of glucose homeostasis in young adults treated with total body irradiation during childhood: a pilot study.
PMID 19308039·Bone Marrow Transplant·2009
8-other
Stem cell engineering for the treatment of severe hemoglobinopathies.
PMID 18991654·Curr Mol Med·2008
6-review
Social support from family and friends as a buffer of low spousal support among mothers of critically ill children: A multilevel modeling approach.
PMID 18823186·Health Psychol·2008
8-other
Transplantation in remission improves the disease-free survival of patients with advanced myelodysplastic syndromes treated with myeloablative T cell-depleted stem cell transplants from HLA-identical siblings.
PMID 18342789·Biol Blood Marrow Transplant·2008
8-other
Fludarabine-based cytoreductive regimen and T-cell-depleted grafts from alternative donors for the treatment of high-risk patients with Fanconi anaemia.
PMID 18302713·Br J Haematol·2008
6-review
A prospective longitudinal multicenter study of coagulation in pediatric patients undergoing allogeneic stem cell transplantation.
PMID 18273869·Pediatr Blood Cancer·2008
4-observational
Fludarabine-based conditioning secures engraftment of second hematopoietic stem cell allografts (HSCT) in the treatment of initial graft failure.
PMID 17950918·Biol Blood Marrow Transplant·2007
3-trial
Long-term follow-up of patients treated with daclizumab for steroid-refractory acute graft-vs-host disease.
PMID 17618322·Bone Marrow Transplant·2007
8-other
Final height in pediatric patients after hyperfractionated total body irradiation and stem cell transplantation.
PMID 17468769·Bone Marrow Transplant·2007
8-other
Transfusion policy: when to stop the use of extremely rare blood for an allogeneic hematopoietic progenitor cell transplant recipient with a history of red cell alloimmunization.
PMID 17465941·Transfusion·2007
5-case
Intravenous busulfan and melphalan, tacrolimus, and short-course methotrexate followed by unmodified HLA-matched related or unrelated hematopoietic stem cell transplantation for the treatment of advanced hematologic malignancies.
PMID 17241929·Biol Blood Marrow Transplant·2007
3-trial
Optimism and life events as predictors of fear appraisals in mothers of children undergoing hematopoietic stem cell transplantation.
PMID 17219398·Psychooncology·2007
4-observational
Therapeutic options for patients with severe beta-thalassemia: the need for globin gene therapy.
PMID 17173507·Hum Gene Ther·2007
6-review
A phase 1/2 trial of arginine butyrate and ganciclovir in patients with Epstein-Barr virus-associated lymphoid malignancies.
PMID 17119113·Blood·2007
3-trial
Unrelated donor bone marrow transplantation for the treatment of Fanconi anemia.
PMID 17038525·Blood·2007
8-other
Immunogenicity of recombinant hepatitis B vaccine (rHBV) in recipients of unrelated or related allogeneic hematopoietic cell (HC) transplants.
PMID 16763208·Blood·2006
8-other
The management of treatment-related esophageal complications in children and adolescents with cancer.
PMID 16516623·J Pediatr Surg·2006
8-other
Changes in mothers' basic beliefs following a child's bone marrow transplantation: the role of prior trauma and negative life events.
PMID 15462540·J Trauma Stress·2004
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1275 YORK AVE
NEW YORK, NY 10021 - Phone
- (212) 639-6684
Quick Facts
- NPI
- 1619948353
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile